 | Up a level |
Ruhstaller, T; Thuss-Patience, P; Hayoz, S; Schacher, S; Knorrenschild, J R; Schnider, A; Plasswilm, Ludwig; Budach, W; Eisterer, W; Hawle, H; Mariette, C; Hess, V; Mingrone, W; Montemurro, M; Girschikofsky, M; Schmidt, S C; Bitzer, M; Bedenne, L; Brauchli, P and Stahl, M (2018). Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08). Annals of oncology, 29(6), pp. 1386-1393. Oxford University Press 10.1093/annonc/mdy105
Schnider, A; Guggisberg, A; Nahum, L; Gabriel, D; Morand, S (2010). Dopaminergic modulation of rapid reality adaptation in thinking. Neuroscience, 167(3), pp. 583-7. Oxford: Elsevier 10.1016/j.neuroscience.2010.02.044
Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; Balmermajno, S; Köberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology, 20(9), pp. 1522-8. Oxford: Oxford University Press 10.1093/annonc/mdp045
